ASCT With TEAM Conditioning for Lymphoma With High Risk of CNS Relapse

NCT07481669 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma Patients With High-risk of Central Nervous System Relapse

Interventions

DRUG: TEAM regimen (thiotepa, etoposide, cytarabine and melphalan)

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University